We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 27

The antidote - September 2014
  • CMS Cameron McKenna
  • European Union, United Kingdom, USA
  • September 9 2014

Summer is nearly at an end and whilst corporate activity continued apace, including AbbVie acquiring Shire, Omega Pharma attracting acquisition


Satellite applications: e-health
  • CMS Cameron McKenna
  • USA
  • February 28 2011

Satellites are playing an increasing role in the support of health and welfare on Earth


Patenting DNA in the US: now you “C” it
  • CMS Cameron McKenna
  • USA
  • July 9 2013

In an eagerly-awaited yet controversial decision, the US Supreme Court has unanimously ruled that naturally-occurring, non-modified sequences of DNA


Lifesciences sector vulnerability to cyber attacks: what to do and how CMS can help
  • CMS Cameron McKenna
  • USA
  • June 17 2015

A recent SCRIP Intelligence article served as a timely reminder of the threat facing the Lifesciences sector through cyber hacks and other technical


Stuart Helmer
  • CMS Cameron McKenna

Sinead Oryszczuk
  • CMS Cameron McKenna

Lucy Kilshaw
  • CMS Cameron McKenna

Joanna Wheeler
  • CMS Cameron McKenna

Valentina Parvu
  • CMS Cameron McKenna

Susan Barty
  • CMS Cameron McKenna